RKDA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Arcadia Biosciences Inc (RKDA).


$8.08M Market Cap.

As of 03/25/2025 5:00 PM ET (MRY) • Disclaimer

RKDA Market Cap. (MRY)


RKDA Shares Outstanding (MRY)


RKDA Assets (MRY)


Total Assets

$13.52M

Total Liabilities

$7.29M

Total Investments

$5.86M

RKDA Income (MRY)


Revenue

$5.04M

Net Income

-$7.04M

Operating Expense

$5.73M

RKDA Cash Flow (MRY)


CF Operations

-$9.63M

CF Investing

$7.34M

CF Financing

$9.00K

RKDA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

RKDA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$13,517,000 (-31.40%)

$19,705,000 (-31.87%)

$28,922,000 (-34.15%)

$43,918,000 (-7.24%)

Assets Current

$9,242,000 (-38.27%)

$14,972,000 (-41.05%)

$25,398,000 (-28.23%)

$35,388,000 (11.65%)

Assets Non-Current

$4,275,000 (-9.68%)

$4,733,000 (34.31%)

$3,524,000 (-58.69%)

$8,530,000 (-45.50%)

Goodwill & Intangible Assets

$39,000 (0.00%)

$39,000 (-2.50%)

$40,000 (-91.74%)

$484,000 (-37.79%)

Shareholders Equity

$6,223,000 (-51.54%)

$12,841,000 (-38.95%)

$21,033,000 (-32.35%)

$31,093,000 (12.15%)

Property Plant & Equipment Net

$178,000 (-84.86%)

$1,176,000 (-53.48%)

$2,528,000 (-52.94%)

$5,372,000 (-42.64%)

Cash & Equivalents

$4,242,000 (-34.92%)

$6,518,000 (-68.43%)

$20,644,000 (-28.03%)

$28,685,000 (78.80%)

Accumulated Other Comprehensive Income

$0 (0%)

$101,000 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$5,860,000 (14.36%)

$5,124,000 (0%)

$0 (0%)

$0 (0%)

Investments Current

$1,894,000 (-63.04%)

$5,124,000 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$3,966,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$904,000 (-82.98%)

$5,312,000 (72.02%)

$3,088,000 (-55.42%)

$6,927,000 (-5.07%)

Trade & Non-Trade Receivables

$1,175,000 (128.60%)

$514,000 (-57.90%)

$1,221,000 (-10.88%)

$1,370,000 (-2.56%)

Trade & Non-Trade Payables

$2,108,000 (-12.53%)

$2,410,000 (-15.59%)

$2,855,000 (-21.52%)

$3,638,000 (-11.38%)

Accumulated Retained Earnings (Deficit)

-$278,878,000 (-2.59%)

-$271,840,000 (-5.42%)

-$257,859,000 (-13.85%)

-$226,485,000 (-6.92%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$155,000 (-84.61%)

$1,007,000 (-50.07%)

$2,017,000 (-38.77%)

$3,294,000 (-64.78%)

Debt Current

$155,000 (-81.81%)

$852,000 (-15.64%)

$1,010,000 (-5.96%)

$1,074,000 (-42.20%)

Debt Non-Current

$0 (0%)

$155,000 (-84.61%)

$1,007,000 (-54.64%)

$2,220,000 (-70.38%)

Total Liabilities

$7,294,000 (4.17%)

$7,002,000 (-12.72%)

$8,022,000 (-36.94%)

$12,722,000 (-32.32%)

Liabilities Current

$2,563,000 (-28.61%)

$3,590,000 (-14.71%)

$4,209,000 (-16.49%)

$5,040,000 (-20.18%)

Liabilities Non-Current

$4,731,000 (38.66%)

$3,412,000 (-10.52%)

$3,813,000 (-50.36%)

$7,682,000 (-38.46%)

RKDA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$5,045,000 (-5.35%)

$5,330,000 (-46.46%)

$9,956,000 (46.84%)

$6,780,000 (-15.61%)

Cost of Revenue

$2,963,000 (-10.21%)

$3,300,000 (-66.33%)

$9,802,000 (12.56%)

$8,708,000 (67.49%)

Selling General & Administrative Expense

$9,641,000 (-33.55%)

$14,508,000 (-19.61%)

$18,048,000 (-21.32%)

$22,938,000 (39.30%)

Research & Development Expense

$53,000 (-96.18%)

$1,387,000 (-8.08%)

$1,509,000 (-61.20%)

$3,889,000 (-51.14%)

Operating Expenses

$5,730,000 (-64.12%)

$15,968,000 (-16.13%)

$19,039,000 (-43.68%)

$33,808,000 (116.54%)

Interest Expense

$0 (0%)

$0 (0%)

-$289,000 (-1545.00%)

$20,000 (-57.45%)

Income Tax Expense

$8,000 (0.00%)

$8,000 (-42.86%)

$14,000 (600.00%)

$2,000 (101.61%)

Net Loss Income from Discontinued Operations

$2,721,000 (231.43%)

$821,000 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$7,038,000 (49.68%)

-$13,986,000 (10.42%)

-$15,612,000 (3.24%)

-$16,134,000 (-167.74%)

Net Income to Non-Controlling Interests

$0 (0%)

-$5,000 (97.88%)

-$236,000 (83.99%)

-$1,474,000 (-7.51%)

Net Income

-$7,038,000 (49.66%)

-$13,981,000 (9.07%)

-$15,376,000 (-4.88%)

-$14,660,000 (-214.93%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$7,038,000 (49.66%)

-$13,981,000 (9.07%)

-$15,376,000 (-4.88%)

-$14,660,000 (-214.93%)

Weighted Average Shares

$1,363,303 (10.22%)

$1,236,934 (106.37%)

$599,389 (12.66%)

$532,016 (113.68%)

Weighted Average Shares Diluted

$1,363,303 (10.22%)

$1,236,934 (106.37%)

$599,389 (12.66%)

$532,016 (113.68%)

Earning Before Interest & Taxes (EBIT)

-$7,030,000 (49.69%)

-$13,973,000 (10.72%)

-$15,651,000 (-6.92%)

-$14,638,000 (-209.34%)

Gross Profit

$2,082,000 (2.56%)

$2,030,000 (1218.18%)

$154,000 (107.99%)

-$1,928,000 (-168.01%)

Operating Income

-$3,648,000 (73.83%)

-$13,938,000 (26.20%)

-$18,885,000 (47.15%)

-$35,736,000 (-179.67%)

RKDA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$7,342,000 (269.01%)

-$4,344,000 (-406.56%)

$1,417,000 (-91.47%)

$16,608,000 (-3.91%)

Net Cash Flow from Financing

$9,000 (-99.84%)

$5,512,000 (21.97%)

$4,519,000 (-79.37%)

$21,900,000 (6.52%)

Net Cash Flow from Operations

-$9,627,000 (37.05%)

-$15,294,000 (-9.42%)

-$13,977,000 (45.97%)

-$25,868,000 (14.40%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$2,276,000 (83.89%)

-$14,126,000 (-75.67%)

-$8,041,000 (-163.61%)

$12,642,000 (65.77%)

Net Cash Flow - Business Acquisitions and Disposals

$2,000,000 (251.49%)

$569,000 (0.00%)

$569,000 (113.39%)

-$4,250,000 (-260.20%)

Net Cash Flow - Investment Acquisitions and Disposals

$5,024,000 (200.02%)

-$5,023,000 (0%)

$0 (0%)

$21,846,000 (28.82%)

Capital Expenditure

$318,000 (189.09%)

$110,000 (-87.03%)

$848,000 (185.83%)

-$988,000 (57.54%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$2,146,000 (-169.81%)

Issuance (Purchase) of Equity Shares

$9,000 (-99.85%)

$6,009,000 (20.18%)

$5,000,000 (-80.13%)

$25,169,000 (52.46%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$2,000 (0%)

Share Based Compensation

$512,000 (-28.59%)

$717,000 (-35.17%)

$1,106,000 (-28.23%)

$1,541,000 (-24.53%)

Depreciation Amortization & Accretion

$765,000 (-22.26%)

$984,000 (-27.81%)

$1,363,000 (-41.28%)

$2,321,000 (35.73%)

RKDA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

41.30% (8.40%)

38.10% (2440.00%)

1.50% (105.28%)

-28.40% (-180.45%)

Profit Margin

-139.50% (46.82%)

-262.30% (-69.88%)

-154.40% (28.58%)

-216.20% (-273.40%)

EBITDA Margin

-124.20% (49.04%)

-243.70% (-69.83%)

-143.50% (21.02%)

-181.70% (-383.24%)

Return on Average Equity (ROAE)

-72.50% (18.26%)

-88.70% (-48.83%)

-59.60% (-59.79%)

-37.30% (-24.33%)

Return on Average Assets (ROAA)

-45.30% (18.67%)

-55.70% (-24.33%)

-44.80% (-86.67%)

-24.00% (-95.12%)

Return on Sales (ROS)

-139.30% (46.87%)

-262.20% (-66.79%)

-157.20% (27.19%)

-215.90% (-266.55%)

Return on Invested Capital (ROIC)

-77.20% (49.54%)

-153.00% (5.96%)

-162.70% (-146.14%)

-66.10% (-237.24%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.15 (-313.36%)

-0.28 (34.52%)

-0.42 (71.97%)

-1.51 (71.97%)

Price to Sales Ratio (P/S)

1.6 (120.39%)

0.73 (11.18%)

0.65 (-79.99%)

3.26 (4.08%)

Price to Book Ratio (P/B)

1.3 (378.97%)

0.27 (-14.78%)

0.32 (-57.14%)

0.74 (-24.90%)

Debt to Equity Ratio (D/E)

1.17 (115.05%)

0.55 (43.04%)

0.38 (-6.85%)

0.41 (-39.68%)

Earnings Per Share (EPS)

-5.17 (54.25%)

-11.3 (55.95%)

-25.65 (6.93%)

-27.56 (-46.60%)

Sales Per Share (SPS)

3.7 (-14.11%)

4.31 (-74.06%)

16.61 (30.34%)

12.74 (-60.51%)

Free Cash Flow Per Share (FCFPS)

-6.83 (44.38%)

-12.28 (43.96%)

-21.9 (56.61%)

-50.48 (61.38%)

Book Value Per Share (BVPS)

4.57 (-56.03%)

10.38 (-70.42%)

35.09 (-39.96%)

58.44 (-47.52%)

Tangible Assets Book Value Per Share (TABVPS)

9.89 (-37.82%)

15.9 (-67.00%)

48.19 (-40.98%)

81.64 (-56.35%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0%)

0 (0%)

1 (0.00%)

1 (120.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.72 (-258.63%)

0.45 (-53.16%)

0.96 (37.46%)

0.7 (108.58%)

Asset Turnover

0.33 (53.30%)

0.21 (-26.90%)

0.29 (161.26%)

0.11 (-47.64%)

Current Ratio

3.61 (-13.53%)

4.17 (-30.89%)

6.03 (-14.06%)

7.02 (39.86%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$9,309,000 (38.69%)

-$15,184,000 (-15.65%)

-$13,129,000 (51.11%)

-$26,856,000 (17.48%)

Enterprise Value (EV)

$4,490,445 (176.57%)

-$5,864,645 (57.46%)

-$13,785,758 (-59.48%)

-$8,644,396 (-134.95%)

Earnings Before Tax (EBT)

-$7,030,000 (49.69%)

-$13,973,000 (9.04%)

-$15,362,000 (-4.80%)

-$14,658,000 (-206.72%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$6,265,000 (51.77%)

-$12,989,000 (9.09%)

-$14,288,000 (-16.00%)

-$12,317,000 (-307.58%)

Invested Capital

$6,828,000 (-35.37%)

$10,565,000 (74.74%)

$6,046,000 (-53.50%)

$13,003,000 (-61.26%)

Working Capital

$6,679,000 (-41.32%)

$11,382,000 (-46.28%)

$21,189,000 (-30.18%)

$30,348,000 (19.57%)

Tangible Asset Value

$13,478,000 (-31.47%)

$19,666,000 (-31.91%)

$28,882,000 (-33.50%)

$43,434,000 (-6.73%)

Market Capitalization

$8,080,445 (132.51%)

$3,475,355 (-47.96%)

$6,678,242 (-71.05%)

$23,071,604 (-15.81%)

Average Equity

$9,708,750 (-38.43%)

$15,767,500 (-38.87%)

$25,792,250 (-34.32%)

$39,270,250 (152.79%)

Average Assets

$15,543,250 (-38.06%)

$25,094,750 (-26.84%)

$34,300,750 (-43.94%)

$61,186,000 (61.81%)

Invested Capital Average

$9,112,000 (-0.21%)

$9,130,750 (-5.10%)

$9,621,750 (-56.56%)

$22,147,500 (-8.34%)

Shares

1,364,940 (22.93%)

1,110,337 (80.23%)

616,074 (11.08%)

554,606 (104.80%)